In 1964, Dr. Raphael Mechoulam isolated THC, the psychoactive compound in cannabis. This groundbreaking work, detailed in the journal Science, set the stage for decades of cannabis research, opening the door to understanding its effects on the human body. 

One of Mechoulam's most remarkable achievements was the discovery of the endocannabinoid system (ECS) in the early 1990s. This system, comprising endocannabinoids, receptors, and enzymes, is crucial for regulating various physiological processes such as mood, pain, appetite, and memory. His work illuminated how cannabinoids interact with the ECS, which was a game-changer for both neuroscience and pharmacology.

Additionally, Mechoulam's research set the stage for the development of cannabis-based medicines. His studies provided the scientific foundation for therapeutic applications, leading to the creation of medications like Epidiolex, used to treat epilepsy, and other treatments targeting pain and nausea. Beyond his technical achievements, Mechoulam's work has had a profound impact on the public and medical perception of cannabis, contributing to the growing acceptance and legalization of medical cannabis worldwide.

If you need help finding your best cannabis regimen, please make an appointment with a cannabis pharmacist at greenbridgehealth.com and check out our resource pages.  

If you would like to get your MMJ card for the first time or just renew it, please go to greenbridgesociety.com for the best service and lowest prices.